Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Why CSL Shares Crashed 24% in a Month — Is This a Healthcare Opportunity or Warning Sign?

CSL Limited (ASX:CSL) has experienced one of its sharpest share price declines in recent years, with the stock falling almost 25% over the past month after management downgraded FY26 expectations and announced substantial additional asset impairments.

Sonal Goyal | 27 May 2026

Is Neuren (ASX:NEU) Stock Worth Watching After Its Latest DAYBUE Update?

Neuren Pharmaceuticals Limited (ASX:NEU) has attracted renewed market attention after its shares climbed more than 13% over the past month, supported by rising DAYBUE sales, growing royalty income and progress across its neurological disorder treatment pipeline.

Sonal Goyal | 27 May 2026

Why Trajan Group Holdings (ASX:TRJ) Shares Dropped Today?

Trajan Group Holdings Limited (ASX:TRJ) released a trading update on 27 May 2026 outlining operational progress across its global business while cautioning investors about the likely effect of currency movements on its FY26 reported results. The update prompted a sharp reaction in the market, …

Sonal Goyal | 27 May 2026

Cryosite's (ASX:CTE) New Facilities, Expanded Margins: A Financial Profile Worth Studying

Shares in Cryosite Limited (ASX:CTE) released a trading update covering the 10 months to April 30, 2026. The stable share price reflects the market's familiarity with Cryosite's consistent financial performance trajectory, with the disclosed metrics — 22% revenue growth and 28% EBITDA growth — …

Sonal Goyal | 27 May 2026

56% in a Year and Still Climbing — What’s Driving Recce Pharmaceuticals' (ASX:RCE) Momentum?

Shares in Recce Pharmaceuticals Limited (ASX:RCE) advanced AUD 0.04 or 7.62% to AUD 0.56 on May 27, 2026, following the company's announcement of a non-binding term sheet for a 10-year exclusive licensing arrangement covering its R327 Topical Gel across the Middle East and North …

Sonal Goyal | 27 May 2026

Imricor (ASX: IMR) Granted ASX Waiver Following US SEC Registration

Imricor Medical Systems Inc (ASX: IMR) has announced that it has secured an ASX waiver from multiple periodic reporting obligations after officially becoming a US public reporting company.

Aditi Sarkar | 27 May 2026

Australian Clinical Labs (ASX:ACL) Shares Draw Attention After Latest Appendix 3C Filing

On 27 May 2026, Australian Clinical Labs Limited (ASX:ACL) lodged an Appendix 3C – Notification of buy-back as an update announcement under the type “daily buy-back notification”. The announcement covers the Company’s ordinary fully paid shares, identified by the ASX security code ACL, and …

Aditi Sarkar | 27 May 2026

Is 4DMedical (ASX:4DX) Becoming a Key Player in Respiratory Imaging?

Shares in 4DMedical (ASX:4DX) moved higher on May 27, with the stock rising 5.4% to $3.50 after the company announced publication of new peer-reviewed clinical data supporting its CT:VQ™ respiratory imaging platform.

Aditi Sarkar | 27 May 2026

EMVision (ASX:EMV) Shares Edge Higher Following Aeromedical Stroke Study Results

EMVision Medical Devices Ltd (ASX:EMV) shares moved modestly higher during the morning session on 27 May 2026 after the company released favourable results from an aeromedical feasibility and usability study involving its First Responder Brain Scanner.

Aditi Sarkar | 27 May 2026

Aurora Labs (ASX:A3D) Signs With MBDA: Why This Teaming Agreement Is Different from MoU

Aurora Labs Limited (ASX:A3D) has taken the next formal step in its relationship with MBDA, the European multi-national defence group jointly owned by Airbus, BAE Systems, and Leonardo. The Teaming Agreement announced on 27 May 2026 replaces the non-binding Memorandum of Understanding signed in …

Sonal Goyal | 27 May 2026
Support

Hi! How can we help you today?

Loading…